MedTrace Logo

Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh

NCT01769144 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2013-02-21

No results posted yet for this study

Summary

This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA) and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.

Conditions

Interventions

DEVICE

Acticoat Absorbent

wound dressing

DEVICE

BCT

wound dressing

Sponsors & Collaborators

  • Bio-medical Carbon Technology Co., Ltd.

    collaborator INDUSTRY

  • Kaohsiung Veterans General Hospital.

    lead OTHER

Principal Investigators

  • Kuei-Chang Hsu, MD · Kaohsiung Veterans General Hospital.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-07-31
Completion
2014-04-30

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01769144 on ClinicalTrials.gov